SCHEMBL6711642

SCHEMBL6711642

O=C(Nc1ccc(Cl)cc1-c1nnn[nH]1)c1cc2ccccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NHERF1 O14745 4/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GAA P10253 2/20 0.47
MGAM O43451 1/20 0.47
SI P14410 1/20 0.47
MGAM2 Q2M2H8 1/20 0.47
EGFR P00533 4/20 0.45
PIK3CA P42336 4/20 0.45
IDO1 P14902 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
PYGL P06737 3/20 0.44
STK33 Q9BYT3 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711906 0.93 NHERF1 (0.46) NHERF1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL6708921 0.92 ALOX15 (0.51) NHERF1MEN1KMT2ARXFP1PYGL
SCHEMBL6709900 0.88 NPC1 (0.47) NPC1RAB9ALMNASMN1; SMN2GAA
SCHEMBL6711816 0.86 PLCG2 (0.44) NHERF1LMNAMEN1KMT2ARXFP1
SCHEMBL6709221 0.85 ALOX15 (0.46) NHERF1PYGL
SCHEMBL6707766 0.85 NPC1 (0.45) NPC1RAB9ALMNASMN1; SMN2GAA
SCHEMBL6713754 0.84 SERPINE1 (0.43) NHERF1GAARXFP1STK33KDM4E
SCHEMBL6712151 0.84 FLT3 (0.48) NPC1RAB9ALMNASMN1; SMN2GAA
SCHEMBL6711722 0.84 KDM4E (0.57) NHERF1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL6710194 0.84 NSD2 (0.50) NHERF1NPC1RAB9ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 NHERF1 1641/4885NPC1 3891/4885RAB9A 3732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.